New insights into pharmacological tools to TR(i)P cancer up

British Journal of Pharmacology

Volumn 171, Issue 10, 2014, Pages 2582-2592

  Gautier, M ^a   Dhennin Duthille, I ^a   Ay, A S ^a   Rybarczyk, P ^a   Korichneva, I ^a   Ouadid Ahidouch, H ^a  

^a Université Picardie Jules Vernes   (France)

Author keywords

Cancer; Cancer targets; Pharmacology; TRP channels

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 AMINOETHOXYDIPHENYLBORANE; 20 O BETA DEXTRO GLUCOPYRANOSIL 20 PROTOPANAXADIOL; ANTINEOPLASTIC AGENT; MRS 1845; N PROPARGYLNIFRENDIPINE; RETINOIC ACID; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 2; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT;

APOPTOSIS; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG EFFECT; DRUG POTENCY; DRUG TARGETING; GLIOMA; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE STEADY POTENTIAL; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; DRUG DESIGN; DRUG EFFECTS; METABOLISM; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; MEMBRANE TRANSPORT MODULATORS; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84900818975     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12561     Document Type: Review

References (82)

1. Alexander S PH, Benson H E, Faccenda E, Pawson A J, Sharman J L, Catterall W A, Spedding M, Peters J A, Harmar A J, and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
2. Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, et al. (2007). Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem 102: 977-990.
3. Amantini C, Ballarini P, Caprodossi S, Nabissi M, Morelli MB, Lucciarini R, et al. (2009). Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 30: 1320-1329.
4. Azad N, Perroy A, Gardner E, Imamura CK, Graves C, Sarosy GA, et al. (2009). A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors. Cancer Biol Ther 8: 1800-1805.
5. Beck B, Bidaux G, Bavencoffe A, Lemonnier L, Thebault S, Shuba Y, et al. (2007). Prospects for prostate cancer imaging and therapy using high-Affinity TRPM8 activators. Cell Calcium 41: 285-294.
6. 2+ entry. Adv Exp Med Biol 740: 349-382.
7. Bode AM, Dong Z, (2011). The two faces of capsaicin. Cancer Res 71: 2809-2814.
8. Bomben VC, Sontheimer H, (2010). Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. Glia 58: 1145-1156.
9. Bomben VC, Sontheimer HW, (2008). Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas. Cell Prolif 41: 98-121.
10. Bomben VC, Turner KL, Barclay TT, Sontheimer H, (2011). Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas. J Cell Physiol 226: 1879-1888.
11. Bon RS, Beech DJ, (2013). In pursuit of small molecule chemistry for calcium-permeable non-selective TRPC channels-mirage or pot of gold? Br J Pharmacol 170: 459-474.
12. Bowen CV, DeBay D, Ewart HS, Gallant P, Gormley S, Ilenchuk TT, et al. (2013). In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin. Plos ONE 8: e58866.
13. Brederson JD, Kym PR, Szallasi A, (2013). Targeting TRP channels for pain relief. Eur J Pharmacol 716: 61-76.
14. Cai R, Ding X, Zhou K, Shi Y, Ge R, Ren G, et al. (2009). Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer 125: 2281-2287.
15. Capasso R, Aviello G, Romano B, Borrelli F, De Petrocellis L, Di Marzo V, et al. (2012). Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects. Br J Pharmacol 165: 1966-1977.
16. Caprodossi S, Amantini C, Nabissi M, Morelli MB, Farfariello V, Santoni M, et al. (2011). Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis 32: 686-694.
17. Chow J, Norng M, Zhang J, Chai J, (2007). TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells-mechanisms behind a possible new 'hot' cancer treatment. Biochim Biophys Acta 1773: 565-576.
18. De Petrocellis L, Ligresti A, Moriello AS, Allara M, Bisogno T, Petrosino S, et al. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163: 1479-1494.
19. Ding X, He Z, Shi Y, Wang Q, Wang Y, (2010a). Targeting TRPC6 channels in oesophageal carcinoma growth. Expert Opin Ther Targets 14: 513-527.
20. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, et al. (2010b). Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 102: 1052-1068.
21. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, et al. (1998). Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 58: 1515-1520.
22. Earley S, (2012). TRPA1 channels in the vasculature. Br J Pharmacol 167: 13-22.
23. Engel MA, Leffler A, Niedermirtl F, Babes A, Zimmermann K, Filipovic MR, et al. (2011). TRPA1 and substance P mediate colitis in mice. Gastroenterology 141: 1346-1358.
24. Fernandes ES, Fernandes MA, Keeble JE, (2012). The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 166: 510-521.
25. Gkika D, Prevarskaya N, (2011). TRP channels in prostate cancer: the good, the bad and the ugly? Asian J Androl 13: 673-676.
26. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H, (2009). Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 297: C493-C502.
27. Guilbert A, Gautier M, Dhennin-Duthille I, Rybarczyk P, Sahni J, Sevestre H, et al. (2013). Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain. Eur J Cancer 49: 3694-3707.
28. Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW, (2003). Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 65: 329-338.
29. He B, Liu F, Ruan J, Li A, Chen J, Li R, et al. (2012). Silencing TRPC1 expression inhibits invasion of CNE2 nasopharyngeal tumor cells. Oncol Rep 27: 1548-1554.
30. Hoenderop JG, Nilius B, Bindels RJ, (2005). Calcium absorption across epithelia. Physiol Rev 85: 373-422.
31. Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, et al. (2004). 2-Aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J Biol Chem 279: 35741-35748.
32. Hwang JA, Hwang MK, Jang Y, Lee EJ, Kim JE, Oh MH, et al. (2013). 20-O-beta-d-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginseng, inhibits colon cancer growth by targeting TRPC channel-mediated calcium influx. J Nutr Biochem 24: 1096-1104.
33. Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, et al. (2012). Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol 166: 1444-1460.
34. Jiang HN, Zeng B, Zhang Y, Daskoulidou N, Fan H, Qu JM, et al. (2013). Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer. PLoS ONE 8: e67637.
35. Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, et al. (2008). Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer 60: 200-207.
36. Kim BJ, (2013). Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J Ginseng Res 37: 201-209.
37. Kim BJ, Nam JH, Kwon YK, So I, Kim SJ, (2013). The role of waixenicin A as transient receptor potential melastatin 7 blocker. Basic Clin Pharmacol Toxicol 112: 83-89.
38. Kissin I, Szallasi A, (2011). Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem 11: 2159-2170.
39. Kohn EC, Figg WD, Sarosy GA, Bauer KS, Davis PA, Soltis MJ, et al. (1997). Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations. J Clin Oncol 15: 1985-1993.
40. Kremeyer B, Lopera F, Cox JJ, Momin A, Rugiero F, Marsh S, et al. (2010). A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 66: 671-680.
41. Lehen'kyi V, Raphael M, Prevarskaya N, (2012). The role of the TRPV6 channel in cancer. J Physiol 590 (Pt 6): 1369-1376.
42. 2+ release. J Biochem 122: 498-505.
43. Middelbeek J, Kuipers AJ, Henneman L, Visser D, Eidhof I, van Horssen R, et al. (2012). TRPM7 is required for breast tumor cell metastasis. Cancer Res 72: 4250-4261.
44. Mikkelsen T, Lush R, Grossman SA, Carson KA, Fisher JD, Alavi JB, et al. (2007). Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme. Invest New Drugs 25: 259-263.
45. Monet M, Gkika D, Lehen'kyi V, Pourtier A, Vanden Abeele F, Bidaux G, et al. (2009). Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 1793: 528-539.
46. Moran MM, McAlexander MA, Biro T, Szallasi A, (2011). Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10: 601-620.
47. Morelli MB, Nabissi M, Amantini C, Farfariello V, Ricci-Vitiani L, Di Martino S, et al. (2012). The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation. Int J Cancer 131: E1067-E1077.
48. Munaron L, Genova T, Avanzato D, Antoniotti S, Fiorio Pla A, (2013). Targeting calcium channels to block tumor vascularization. Recent Pat Anticancer Drug Discov 8: 27-37.
49. Nabissi M, Morelli MB, Santoni M, Santoni G, (2013). Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34: 48-57.
50. Naylor J, Milligan CJ, Zeng F, Jones C, Beech DJ, (2008). Production of a specific extracellular inhibitor of TRPM3 channels. Br J Pharmacol 155: 567-573.
51. Nilius B, Owsianik G, Voets T, Peters JA, (2007). Transient receptor potential cation channels in disease. Physiol Rev 87: 165-217.
52. Okamoto Y, Ohkubo T, Ikebe T, Yamazaki J, (2012). Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines. Int J Oncol 40: 1431-1440.
53. Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, Sevestre H, Ahidouch A, (2013). TRP channels: diagnostic markers and therapeutic targets for breast cancer? Trends Mol Med 19: 117-124.
54. Oulidi A, Bokhobza A, Gkika D, Vanden Abeele F, Lehen'kyi V, Ouafik L, et al. (2013). TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion, migration and invasion. PLoS ONE 8: e64885.
55. Preti D, Szallasi A, Patacchini R, (2012). TRP channels as therapeutic targets in airway disorders: a patent review. Expert Opin Ther Pat 22: 663-695.
56. Prevarskaya N, Zhang L, Barritt G, (2007). TRP channels in cancer. Biochim Biophys Acta 1772: 937-946.
57. Prevarskaya N, Skryma R, Shuba Y, (2011). Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11: 609-618.
58. Ramer R, Hinz B, (2008). Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 100: 59-69.
59. Ramer R, Merkord J, Rohde H, Hinz B, (2010). Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochem Pharmacol 79: 955-966.
60. Romanovsky AA, Almeida MC, Garami A, Steiner AA, Norman MH, Morrison SF, et al. (2009). The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 61: 228-261.
61. Rybarczyk P, Gautier M, Hague F, Dhennin-Duthille I, Chatelain D, Kerr-Conte J, et al. (2012). Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int J Cancer 131: E851-E861.
62. Sanchez AM, Sanchez MG, Malagarie-Cazenave S, Olea N, Diaz-Laviada I, (2006). Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11: 89-99.
63. Santoni G, Farfariello V, (2011). TRP channels and cancer: new targets for diagnosis and chemotherapy. Endocr Metab Immune Disord Drug Targets 11: 54-67.
64. Schaefer EA, Stohr S, Meister M, Aigner A, Gudermann T, Buech TR, (2013). Stimulation of the chemosensory TRPA1 cation channel by volatile toxic substances promotes cell survival of small cell lung cancer cells. Biochem Pharmacol 85: 426-438.
65. Shapovalov G, Lehen'kyi V, Skryma R, Prevarskaya N, (2011). TRP channels in cell survival and cell death in normal and transformed cells. Cell Calcium 50: 295-302.
66. Shi Y, Ding X, He ZH, Zhou KC, Wang Q, Wang YZ, (2009). Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Gut 58: 1443-1450.
67. Singh A, Hildebrand ME, Garcia E, Snutch TP, (2010). The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-Activated T-type calcium channels. Br J Pharmacol 160: 1464-1475.
68. Stadler WM, Rosner G, Small E, Hollis D, Rini B, Zaentz SD, et al. (2005). Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma-CALGB 69901. J Clin Oncol 23: 3726-3732.
69. Stock K, Kumar J, Synowitz M, Petrosino S, Imperatore R, Smith ES, et al. (2012). Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. Nat Med 18: 1232-1238.
70. Sung B, Prasad S, Ravindran J, Yadav VR, Aggarwal BB, (2012). Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors. Free Radic Biol Med 53: 1977-1987.
71. Trevisan G, Materazzi S, Fusi C, Altomare A, Aldini G, Lodovici M, et al. (2013). Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade. Cancer Res 73: 3120-3131.
72. Valero M, Morenilla-Palao C, Belmonte C, Viana F, (2011). Pharmacological and functional properties of TRPM8 channels in prostate tumor cells. Pflugers Arch 461: 99-114.
73. Valero ML, Mello de Queiroz F, Stuhmer W, Viana F, Pardo LA, (2012). TRPM8 ion channels differentially modulate proliferation and cell cycle distribution of normal and cancer prostate cells. PLoS ONE 7: e51825.
74. Vay L, Gu C, McNaughton PA, (2012). The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol 165: 787-801.
75. Venkatachalam K, Montell C, (2007). TRP channels. Annu Rev Biochem 76: 387-417.
76. Vennekens R, Owsianik G, Nilius B, (2008). Vanilloid transient receptor potential cation channels: an overview. Curr Pharm Des 14: 18-31.
77. Waning J, Vriens J, Owsianik G, Stuwe L, Mally S, Fabian A, et al. (2007). A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration. Cell Calcium 42: 17-25.
78. Wu LJ, Sweet TB, Clapham DE, (2010). International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev 62: 381-404.
79. Xu SZ, (2011). Assessing TRPC channel function using pore-blocking antibodies. 2012/05/18 edn., Zhu RTX, (ed.). TRP Channels. CRC Press: Boca Raton, FL, pp. 149-166.
80. Zhang L, Barritt GJ, (2006). TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr Relat Cancer 13: 27-38.
81. Zholos A, (2010). Pharmacology of transient receptor potential melastatin channels in the vasculature. Br J Pharmacol 159: 1559-1571.
82. Zierler S, Yao G, Zhang Z, Kuo WC, Porzgen P, Penner R, et al. (2011). Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels. J Biol Chem 286: 39328-39335.